RETRACTED ARTICLE: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer.
- DOI
- 10.1007/s10585-019-10010-5
- Published
- 2021 Apr
- Container
- Clinical & experimental metastasis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10585-019-10010-5,
title = {RETRACTED ARTICLE: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer.},
author = {Antonio CCP and Francisco-Cristobal MC and Alida GG and Susana SG and Israel M and Rafael M and David PV and Pedro V and Fernando P and Elena G and José G and Spanish Peritoneal Surgical Oncology Group (GECOP)},
year = {2021},
journal = {Clinical \& experimental metastasis},
doi = {10.1007/s10585-019-10010-5},
url = {https://doi.org/10.1007/s10585-019-10010-5}
}RIS
TY - JOUR TI - RETRACTED ARTICLE: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer. AU - Antonio CCP AU - Francisco-Cristobal MC AU - Alida GG AU - Susana SG AU - Israel M AU - Rafael M AU - David PV AU - Pedro V AU - Fernando P AU - Elena G AU - José G AU - Spanish Peritoneal Surgical Oncology Group (GECOP) PY - 2021 JO - Clinical & experimental metastasis DO - 10.1007/s10585-019-10010-5 UR - https://doi.org/10.1007/s10585-019-10010-5 ER -
APA
CCP, A., MC, F., GG, A., SG, S., M, I., M, R., PV, D., V, P., P, F., G, E., G, J., & (GECOP), S. P. S. O. G. (2021). RETRACTED ARTICLE: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer.. Clinical & experimental metastasis. https://doi.org/10.1007/s10585-019-10010-5
Source records
- pubmed · retrieved 2026-09-25T21:02:54.895Z